Active — Not RecruitingNot Applicable

Impact of Medications Review on Potentially Inappropriate Medications and Clinical Outcomes Among Hospitalized Older Adults

Malaysia500 participantsStarted 2023-07-06

Plain-language summary

The goal of this randomized controlled trial is to assess the effectiveness of a pharmacist-led medication review using the locally developed Malaysian Potentially Inappropriate Prescribing Screening tool in Older Adults (MALPIP), an explicit criteria in hospitalized older adults. The main questions it aims to answer are: 1. The effectiveness of the intervention in reducing the number of PIMs and chronic medications after discharge 2. The impact of the intervention on quality of life, falls events, emergency department visits, readmissions and survivals Researchers will compare the control group to see if there is corresponding changes to the outcomes specified above.

Who can participate

Age range60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 60 years and above * Taking more than five regular drugs * Having at least one chronic medical condition * Ability to understand and speak Malay, English, or Mandarin language Exclusion Criteria: * Admitted for end-of-life care * Diagnosed with terminal illness * Diagnosed with active cancer * Participated in another drug trial * Refused or unable to give consent * Visited the Emergency Department without admission to ward * Readmitted and have been previously enrolled in the trial

What they're measuring

Number of potentially inappropriate medications

Timeframe: Admission up to 18 months

Number of chronic medications

Timeframe: Admission up to 18 months

Trial details

NCT IDNCT05875623

SponsorMonash University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-28

View on ClinicalTrials.gov More Deprescriptions trials